Genetic testing in hereditary melanoma - 24/08/11
Boston, Massachusetts
Abstract |
Advances in our understanding of molecular genetics bring about unique challenges in our ability to practice molecular medicine. With the availability of commercial testing for various genetic cancer syndromes, including hereditary melanoma, specific issues regarding its use and limitations require attention before full translation of this tool into the clinical setting.
Le texte complet de cet article est disponible en PDF.Plan
Supported by the Dermatology Foundation and in part by grants from the American Skin Association (Dr Tsao) and National Institutes of Health (Dr Tsao). Conflicts of interest: None identified. Reprints not available from the authors. |
Vol 51 - N° 5
P. 803-808 - novembre 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?